Literature DB >> 14313512

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

G A SCHUMACHER, G BEEBE, R F KIBLER, L T KURLAND, J F KURTZKE, F MCDOWELL, B NAGLER, W A SIBLEY, W W TOURTELLOTTE, T L WILLMON.   

Abstract

Entities:  

Keywords:  CLINICAL RESEARCH; DRUG THERAPY; MODELS, THEORETICAL; MULTIPLE SCLEROSIS

Mesh：

Year:  1965        PMID： 14313512     DOI： 10.1111/j.1749-6632.1965.tb20235.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  261 in total

Review 1.  Interferon in relapsing-remitting multiple sclerosis.

Authors:  G P Rice; B Incorvaia; L Munari; G Ebers; C Polman; R D'Amico; G Filippini
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 2.  Immunologic therapy for relapsing-remitting multiple sclerosis.

Authors:  H J MacLean; M S Freedman
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

3.  The course of early-onset multiple sclerosis in Iraqi children.

Authors:  Hasan A Al-Hamadani; Atheer S Abdalla; Atheer J Al-Saffar
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

4.  Intrathecal effects of daclizumab treatment of multiple sclerosis.

Authors:  B Bielekova; N Richert; M L Herman; J Ohayon; T A Waldmann; H McFarland; R Martin; G Blevins
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

5.  The diagnostic challenge of multiple sclerosis.

Authors:  T P Seland
Journal:  Can Fam Physician       Date:  1984-07       Impact factor: 3.275

6.  EDMUS, a European database for multiple sclerosis.

Authors:  C Confavreux; D A Compston; O R Hommes; W I McDonald; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

7.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  Clinical viral infections and multiple sclerosis.

Authors:  W A Sibley; C R Bamford; K Clark
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

9.  Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Authors:  J H Noseworthy; P C O'Brien; B G van Engelen; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

10.  MRI in the investigation of patients with myelopathy thought to be due to multiple sclerosis.

Authors:  A Papadopoulos; A Gouliamos; S Trakadas; A Kalovidouris; P Sgouropoulos; S Gatzonis; L Vlahos
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.